Hypoglycemic effect of copper(II) acetate imidazole complexes

Biological Trace Element Research

Volumn 54, Issue 2, 1996, Pages 143-151

  Abdul Ghani, Abdul Salam ^a   Abu Hijleh, Abdul Latif ^a   Nahas, Nabeel ^a   Amin, Riyad ^a  

^a BIRZEIT UNIVERSITY   (Palestine)

Author keywords

Copper(II) complexes; glucose tolerance test; hypoglycemia; streptozotocin induced diabetes

Indexed keywords

ACETIC ACID DERIVATIVE; COPPER COMPLEX; GLUCOSE; IMIDAZOLE DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0029784704     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786261     Document Type: Article

References (19)

1. J. R. J. Sorenson, Copper chelates as possible active forms of antiarthritic agents. J. Med. Chem. 19, 135-148 (1976).
2. D. H. Brown, W. E. Smith, and J. W. Teape, Anti-inflammatory effects of some copper complexes. J. Med. Chem. 23, 729-734 (1980).
3. J. R. J. Sorenson, L. W. Oberley, V. Kishore, Copper complexes: A physiologic approach to the treatment of inflammatory diseases. Inorg. Chim. Acta. 91, 285-294 (1984).
4. J. R. J. Sorenson, The anti-inflammatory activities of copper complexes. In Metal Ions in Biological Systems, vol. 4, Sigel, ed. Marcel Dekker, New York, pp. 77-124 (1982).
5. J. R. J. Sorenson, Copper chelates as possible active metabolites of the antiarthritic and antiepileptic drugs. J. Appl. Nutr. 32, 4-9 (1980).
6. J. R. J. Sorenson, L. W. Oberley, R. K. Crouch, T. W. Kensler, V. Kishore, S. W. C. Leuthauser, T. D. Oberley and A. Pezeshk, Pharmacologic activities of copper compounds in chronic disease. Biol. Trace. Element Res. 5, 257-274 (1983).
7. J. R. J. Sorenson, Copper complexes offer a physio-logical approach to treatment of chronic diseases. Prog. Med. Chem. 26, 437-568 (1989) and references therein.
8. 2 in the rat. Diabetologia 24, 437-440 (1993).
9. A. M. Cohen, A. Teitelbaum, E. Miller, V. Bentor, and M. Field, Effect of copper on carbohydrate metabolism in rats. Isr. J. Med. Sci. 18, 841-844 (1982).
10. E. P. Saggerson, S. R. Sooranna, and C. J. Evans, Insulin like action of nickel and other transition metal ions in rat fat cells. Biochem. J. 154, 349-357 (1976).
11. A. M. Cohen and E. Miller, Effect of copper on insulin release by the intact rat pancreas and the perfused rat pancreas. Pancreas 1(4) 309-316 (1986).
12. P. Y. Boukan, E. A. Busnot, F. Busnot, A. Leclaire, and T. A. Bernard, Structure du Di-μ-acetato-bis[acetato bis(methyl-1 imidazole) cuivre(II)] Hexahydrate. Acta. Cryst. B38, 2458-2461 (1982).
13. A. L. AbuHijleh, C. Woods and I. Y. Ahmed, Synthesis and molecular structure of monomeric copper(II) acetate with 2-methylimidazole and 1,2-dimethylimidazole. Inorg. Chim. Acta. 190, 11-17 (1991).
14. A. L. AbuHijleh and C. Woods, Synthesis, spectroscopic and structural characterization of bis(acetato)tetrakis(imidazole) copper(II): a model complex of DNA binding. Inorg. Chim. Acta, 194, 9-14 (1992).
15. M. E. Washka and E. W. Rice, Determination of glucose by an improved "glucostat(Equation Presented) procedure. Clin. Chem. 7, 542-545 (1961).
16. R. L. Dormer, A. L. Kerbey, M. McPherson, S. Manely, S. J. H. Asheroft, J. G. Schofield and P. J. Randle, The effect of nickel on secretory systems. Biochem. J. 140, 135-142 (1973).
17. J. C. Henquin and A. Lambert, Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am. J. Physiol. 228, 1669-1677 (1975).
18. ++ upon secretion of insulin and glucagon from the perfused canine pancreas. Diabetologia 15, 475-479 (1978).
19. T. Gafgazi, M. L. McDaniel, and P. E. Lacy, Zinc induced inhibition of insulin secretion from isolated rat islets of Langerhans. Diabetes 30, 341-345 (1981).